Medical Science News

RSS

Needle-free mRNA vaccines protect mice against COVID-19 and flu

A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way to deliver mRNA vaccines while limiting unwanted inflammation.

22 Oct 2026

LSD speeds up brain waves and increases neural complexity, study finds

First synthesized in a laboratory in 1938 by the Swiss chemist Albert Hofmann, lysergic acid diethylamide, better known by its acronym LSD, is one of the most potent and most extensively studied psychedelics.

22 Oct 2026

INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar

INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to support international access, distribution and commercialization of Ebstrocel™, the Company’s allogeneic stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB).

From INmune Bio 22 Oct 2026

Stem cell therapies may need new protein quality control standards

Current Good Manufacturing Practice (GMP) standards for cell therapies assess identity, viability, sterility, and genetic stability. For extracellular vesicle (EV) products, Minimal Information for Studies of Extracellular Vesicles (MISEV2023) guidance adds particle size, concentration, markers, morphology, contaminants, endotoxin, and assays.

22 Oct 2026

Review offers guidance for managing recurrent catheter-related bloodstream infections

Patients who depend on long-term intravenous catheters for chemotherapy, hemodialysis, intravenous nutrition and other essential therapies face an ongoing risk of catheter-related bloodstream infections, a potentially life-threatening complication that can be difficult to manage when the device remains necessary for care.

22 Oct 2026

Southampton scientists explore immune cell reprogramming to fight common viruses

Scientists have started work on a new way to fight cold and flu viruses by reprogramming the cells in our immune system to respond faster to infections.

21 Oct 2026

Global study aims to map brain changes across eight psychiatric disorders

Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC will lead a worldwide effort to map how eight common psychiatric disorders affect brain function, supported by a five-year, $3.2 million grant from the National Institutes of Health.

21 Oct 2026

Prenatal iron deficiency linked to lasting changes in the offspring brain

During the first weeks of pregnancy, developing cells are already laying the foundation for the brain. Iron plays a major role in the organization and shaping of cells during this stage of gestation.

21 Oct 2026

Study identifies blood proteins associated with aggressive prostate cancer risk

Proteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes, were associated with the future risk of developing prostate cancer, including aggressive disease, in a new study led by researchers at Oxford Population Health.

21 Oct 2026

Like father, like son? Study reveals a surprising pattern in male reproductive health

Researchers examining 117 father-son pairs from Denmark and Finland identified weak but statistically significant familial associations in several male reproductive traits, including testicular size, sperm concentration, selected hormone levels, and genital measurements. The findings suggest that reproductive characteristics show limited resemblance across generations, although the study could not determine the relative contributions of genetic and environmental factors.

21 Oct 2026

Beef can fit into healthy diets, but what about its environmental cost?

A narrative review published in Animal Frontiers highlights beef's contribution to high-quality protein and bioavailable micronutrients, while controlled trials generally found no adverse effects on selected cardiometabolic risk markers, although long-term disease outcomes remain uncertain. The authors argue that sustainable food policies should consider nutritional needs, environmental impacts, agricultural productivity, and rural livelihoods when evaluating beef's place in healthy diets.

21 Oct 2026

Semaglutide and teduglutide reduce immune-driven gut injury in mice

Researchers found that gut-derived GLP-1 and GLP-2 signaling helped protect mice against T cell-induced intestinal injury, with GLP-1R primarily regulating inflammation and GLP-2R supporting intestinal repair. Semaglutide and teduglutide, administered separately or together, reduced acute intestinal damage in mice lacking intestinal proglucagon, suggesting potential avenues for investigating treatments for immune-mediated gut injury.

21 Oct 2026

Blocking specific proteins protects beta cells om excessive cellular stress

Researchers at Weill Cornell Medicine have identified a molecular pathway that contributes to the death of insulin-producing beta cells in the pancreas.

21 Oct 2026

Glucose priming may improve tumor targeting for chemotherapy nanocarriers

Chemotherapy selectivity is limited by systemic toxicity. pH‑sensitive nanocarriers exploit tumor acidity as a release trigger but respond passively to a modest, heterogeneous gradient.

21 Oct 2026

Study identifies new genetic factors underlying fat accumulation in the liver

Researchers at Karolinska Institutet have identified additional genetic factors underlying fat accumulation in the liver.

21 Oct 2026

Altered fatty acid metabolism drives glioblastoma growth and treatment resistance

Glioma is the most common primary malignant brain tumor in adults, and glioblastoma (GBM), particularly IDH (Isocitrate dehydrogenase)-wildtype disease, has the poorest prognosis.

21 Oct 2026

Greenwood Genetic Center researcher wins major grant to explore cellular metabolism and glycosylation

Heather Flanagan-Steet, PhD, Associate Director of Research at the Greenwood Genetic Center (GGC), has received a $1.4 million, five-year Maximizing Investigators' Research Award (MIRA) R35 grant from the National Institutes of Health's National Institute of General Medical Sciences.

21 Oct 2026